Korean J Ophthalmol.  2005 Sep;19(3):179-182. 10.3341/kjo.2005.19.3.179.

The Clinical Significance of Venous Filling Time through Panretinal Photocoagulation in Proliferative Diabetic Retinopathy

Affiliations
  • 1Department of Ophthalmology, Wonkwang University College of Medicine, Iksan, Jeonbuk, Korea. ysyang@wonkwang.ac.kr
  • 2Department of Genome Research Center for Immune Disorders, Wonkwang University College of Medicine, Iksan, Jeonbuk, Korea.

Abstract

PURPOSE
To verify the clinical correlation between retinopathy progression and the change of venous filling time (VFT), measured before and after panretinal photocoagulation (PRP), in proliferative diabetic retinopathy (PDR) patients. METHODS: We conducted this study on 32 patients (32 eyes) who received PRP for PDR. These patients were subdivided into two groups in accordance with the clinical course of PRP: the stabilized group in which retinal neovascularization was regressed and the progressed group in which retinal neovascularization was continued and a complication, such as vitreous hemorrhage or tractional retinal detachment, was developed within 12 months of laser treatment. Arteriovenous passage time (AVP) and VFT were measured by video fluorescein angiogram (FAG) using scanning laser ophthalmoscope (SLO) before and after PRP. VFT values were assigned by measuring by the time duration from start of venous lamina flow to the fullness of fluorescence on the vascular arch. RESULTS: In the stabilized group, AVP was decreased by 0.20+/-0.89sec and VFT was decreased by 0.30+/-1.69 sec through PRP. In the progressed group, AVP was increased in 0.12+/-1.22 sec and VFT was increased by 0.99+/-1.60 sec through PRP. In both groups, the VFT changes were significant (P=0.04) but the AVP changes were not (P=0.34). CONCLUSIONS: VFT was significantly decreased in the stabilized group and significantly increased in the progressed group after PRP. Accordingly, we suggest that VFT changes after PRP can be utilized as a prognostic indicator for evaluating clinical course of diabetic retinopathy after performing PRP and for monitoring the clinical effect of PRP.

Keyword

Arteriovenous passage time (AVP) ; Panretinal photocoagulation (PRP) ; Proliferative diabetic retinopathy (PDR) ; Venous filling time (VFT)

MeSH Terms

Veins
Time Factors
Retinal Vessels/*physiopathology
Regional Blood Flow
*Light Coagulation
Humans
Diabetic Retinopathy/*physiopathology/*surgery

Figure

  • Fig. 1 Measurement of circulation time; A. Pre-fluorescein fundus image. B. Fluorescent front is seen on the upper termopral artery at a point 2 disc diameters away from the optic disc margin. C. Fluorescent lamina flow is started in the measurement point of the retinal vein. D. In the middle of venous lamina filling, complete filling of the vein. Arteriovenous Passage time (AVPT); time interval taken from B to C. Venous filling time (VFT); time interval taken from B to C.

  • Fig. 2 Differences of each retinal circulation time between after PRP and before PRP in each group. △AVT*: arteriovenous transit time difference between after PRP and before PRP, △VFT†: venous filling time difference between after PRP and before PRP, Regres. G.‡: group with new vessel regressed after PRP, Non-reg. G.§: group with new vessel not regressed and developed complication after PRP.


Reference

1. Kohner EM, Oakley NW. Diabetic retinopathy. Metabolism. 1975. 24:1085–1088.
2. Frank RW. Ryan ST, Ogden TE, Hinton DR, editors. Etiologic Mechanisms in diabetic retinopathy. Retina. 2001. v. 2:3rd ed. St. Louis: Mosby;chap. 71.
3. Harris A, Bingaman DP, Ciulla TA, Martin BJ. Ryan SJ, Ogden TE, Hinton DR, editors. Retina and choroidal blood flow in health and disease. Retina. 2001. v. 1:3rd ed. St. Louis: Mosby;chap. 5.
4. Yang YS, Kang PS, Hwang JY, Kim JD. A Study on Microcirculation Time Including Retinal Periphery in Diabetic Retinopathy using the Fluorescein Angiography. J Korean Ophthalmol Soc. 2000. 41:931–937.
5. Wolf S, Jung F, Kiesewetter H, et al. Videofluorescein angiography; methods and application. Graefes Arch Clin Exp Ophthalmol. 1989. 227:145–151.
6. Kang HR, Yang YS. Comparison of Venous Filling Times and SLO Findings at Each Quadrant Region in Diabetic Retinopathy. Korean J Ophthalmol. 2003. 17:133–139.
7. Pae CH, Kim SD, Yang YS. The Comparison of Venous Filling Time Before and After Panretinal Photocoagulation in Proliferative Diabetic Retinopathy. J Korean Ophthalmol Soc. 2003. 44:338–343.
8. Jang SS, Yang YS. The Clinical Usefulness of the Venous Filling Time in Proliferative Diabetic retinopathy. J Korean Ophthalmol Soc. 2004. 45:976–981.
9. Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy: diabetic retinopathy study report No.14. Int Ophthalmol Clin. 1987. 27:239–253.
10. Diabetic Retinopathy Study Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976. 81:383–396.
11. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985. 193:1796–1806.
12. Ferris FL III. How effective is treatment for diabetic retinopathy? JAMA. 1993. 269:1290–1291.
13. Wolbarsth ML, Landers MB. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review of a model. Ophthalmic Surg. 1980. 11:235–240.
14. Galsser BM, Campchiaro PA, Davis JL Jr. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol. 1985. 103:1870–1875.
15. Woo JH, Heo JW, Yoon HS. The Effect of Panretinal Photocoagulation on Macular Microcirculation in Diabetic Retinopathy(Short term follow up). J Korean Ophthalmol Soc. 1999. 40:1276–1280.
16. Blair NP, Feke GT, Morales-Stoppello J, et al. Prolongation of the Retinal Mean Circulation Time in Diabetes. Arch Ophthalmol. 1982. 100:764–768.
17. Niki T, Muraoka K, Shimizu K. Distribution of capillary nonperfusion in early stage diabetic retinopathy. Ophthalmology. 1984. 91:1431–1439.
18. Lim KH, Lee JH. Study on retinal circulation by Scanning Laser Ophthalmoscope. I. Evaluation of retinal circulation times in Non-proliferative Diabetic Retinopathy. J Korean Ophthalmol Soc. 1995. 36:1133–1136.
19. Bertram B, Arend O, Moritz A, et al. Retinal hemodynamics in diabetic retinopathy before and after laser coagulation. Klin Monatsbl Augenheilkd. 1996. 208:152–156.
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr